AZD4547 OPTIONS

 one prior program of chemotherapy for Highly developed breast cancer and across the complete demo, past publicity to any FGFR inhibitor, key medical procedures or radiotherapy in four months prior to initial dose of research remedy and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac standards precluded cli